Timothy R. Franson's most recent trade in Cidara Therapeutics Inc was a trade of 42,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 22, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cidara Therapeutics Inc | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 42,500 | 42,500 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Timothy R. Franson | Director | Sale of securities on an exchange or to another person at price $ 1.88 per share. | 21 Feb 2023 | 7,000 | 72,000 (0%) | 0% | 1.9 | 13,160 | Common Stock |
| Paratek Pharmaceuticals Inc. | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 20,000 | 79,000 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 20,000 | 59,000 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Timothy R. Franson | Director | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 13 Sep 2021 | 7,000 | 11,000 (0%) | 0% | 2.1 | 14,823 | Common Stock |
| Cidara Therapeutics Inc | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 17,500 | 17,500 | - | - | Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 9,000 | 39,000 (0%) | 0% | 0 | Common Stock | |
| Paratek Pharmaceuticals Inc. | Timothy R. Franson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,000 | 7,000 | - | - | Stock Option (right to buy) |